Provis Biolabs

News & Milestones

Building the Future of Biotechnology

Since our inception in 2019, Provis Biolabs has continuously pushed the boundaries of sustainable biotech manufacturing, transforming ideas into globally trusted solutions.

Apr 2026

ISO 13485 Certified

Provis Biolabs achieved ISO 13485 certification, the internationally recognised standard for quality management systems in the medical device and in vitro diagnostics industry.

Oct 2025

Corporate Headquarters Expansion

Expanded corporate headquarters to support growing global operations, strengthening leadership, business development and administrative teams.

Aug 2025

Global Distribution Expansion

Expanded global distribution network, forming partnerships to deliver Provis Biolabs products to life science customers worldwide.

Mar 2025

USA Commercial Operations Launched

Established Provis Biolabs Inc. in East Hartford, Connecticut, officially launching commercial operations in the United States market.

Aug 2024

New Manufacturing Plant Commissioned

Commissioned a new, cutting-edge manufacturing plant in Jadcherla, Hyderabad, significantly scaling up production capacity to meet global demand.

Oct 2023

Protein & Peptide R&D Expansion

Expanded R&D capabilities into recombinant proteins and synthetic peptides, broadening the product pipeline for global life science markets.

Dec 2022

Bio-Manufacturing Facility Groundbreaking

Broke ground on a state-of-the-art bio-manufacturing facility, marking a pivotal step toward large-scale GMP production capacity.

Jun 2022

Expansion of Recombinant Enzyme Portfolio

Significantly expanded our recombinant enzyme portfolio, adding new specialty enzymes for bioprocessing and analytical workflows.

Apr 2021

Initial Product Portfolio Commercialized

Launched the initial commercial product portfolio of recombinant enzymes and bioreagents to the Indian biopharma market.

Jan 2021

First cGMP Certification Achieved

Achieved our first cGMP certification, establishing a strong quality foundation across all product lines.

Jan 2020

R&D Center Established

Established a dedicated R&D center to develop a pipeline of biotechnology products including Bio-APIs and recombinant reagents.

Sep 2019

Founded & Incubated at Aspire BioNEST

Provis Biolabs Pvt. Ltd. founded by Dr. Bala Reddy. R&D operations commenced at the Aspire-BioNest incubator at the University of Hyderabad.

"Innovation is at the heart of our journey. Every milestone we achieve is a step closer to a sustainable biotech future"